Sargunan Sockalingam

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq et al. · The Lancet Rheumatology · 2019 · 162 citations

Life Sciences, Clinical Sciences, Immunology +13

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Vera Golder, Rangi Kandane‐Rathnayake, Alberta Hoi et al. · Arthritis Research & Therapy · 2017 · 140 citations · Full text

Pharmacy, Health Sciences, Health Assessment +16

Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Diane Apostolopoulos, Rangi Kandane‐Rathnayake, Worawit Louthrenoo et al. · The Lancet Rheumatology · 2019 · 89 citations

Life Sciences, Immunology, Autoimmunity +11

Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

Rangi Kandane‐Rathnayake, Vera Golder, Worawit Louthrenoo et al. · The Lancet Rheumatology · 2022 · 67 citations

Medicine, Health Sciences, Autoimmunity +12

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq et al. · The Lancet Rheumatology · 2019 · 60 citations

Life Sciences, Immunology, Internal Medicine +15